BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:40 PM
Sep 24, 2009
 |  BC Extra  |  Company News

Amsterdam Molecular names CEO

Gene therapy company Amsterdam Molecular Therapeutics (Euronext:AMT) hired Jorn Aldag as CEO. Aldag,...

Read the full 50 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >